[1] Sorrell TC.Cryptococcus neoformans variety gattii[J].Med Mycol,2001,39(2):155-168.
[2] Robinson RF,Nahata MC.A comparative review of conventional and lipid formulations of amphotericin B[J].Clin Pharm Ther,1999,24(4):249-257.
[3] 殷凯生,王彤.国产注射用两性霉素B脂质体治疗深部真菌病的疗效与安全性的临床研究[J].中华医院感染学杂志,2004,14(8):850-853.
[4] Johnson MD,Drew RH,Perfect JR.Chest discomfort associated with liposomal amphotericin B:report of three care and review of the literature[J].Pharmacotherapy,1998,18(5):1053-1061.
[5] Roden MM,Nelson LD,Knudsen TA,et ai.Trial of acute infusionrelated reactions nsseciated with liposomal amphotericin B:analysis of clinical and epidemiological characteristics[J].Clin Infect Dis,2003,36(10):1213-1220.
[6] Stuecklin-Utsch A,Hasan C,Bode U,et al.Pancreatic toxicity after liposomal amphotericin B[J].Mycoses,2002,45(5-6):170-173. |
